A historic collaboration unites the Alzheimer's, frontotemporal dementia, and ALS communities in an effort to characterize the very first publicly readily available TDP43 mouse design at ALS TDI. Riluzole: scientific trials with ALS people showed that Riluzole prolongs survival by several months, largely in Those people with problems swallowing. T… Read More